Lipocine Inc. (LPCN) by event type
LPCN moves most on rating reiterations — a median of -0.05% at 30 minutes across 14 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the LPCN overview →
How LPCN reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 1,104 of 2,283 | 54 | 0.00% | 44% | -0.84% |
| Rating reiterations 2,226 of 3,522 | 14 | -0.05% | 50% | +0.92% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how LPCN usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · LPCN overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PROVECTUS BIOPHARMS (PVCT) | 220 | +0.01% | 50% |
| TG Therapeutics, Inc. (TGTX) | 220 | -0.06% | 47% |
| Mettler-Toledo International, Inc. (MTD) | 219 | -0.10% | 39% |
| AngioDynamics, Inc. (ANGO) | 218 | +0.33% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.